Relationship of myoma cell size and menopausal status in small uterine leiomyomas

Archives of Pathology and Laboratory Medicine

Volumn 124, Issue 10, 2000, Pages 1448-1453

  Cramer, S F ^a   Marchetti, C ^a   Freedman, J ^a   Padela, A ^a  

^a ROCHESTER GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL SIZE; CONTROLLED STUDY; CORRELATION FUNCTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENOPAUSE; MYOMA; PATHOPHYSIOLOGY; POSTMENOPAUSE; TUMOR VOLUME; UTERUS MYOMA;

CELL SIZE; FEMALE; HUMANS; LEIOMYOMA; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; UTERINE NEOPLASMS;

EID: 0033793983     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy-Efficacy and ultrasonographic indicators
2. Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists-The estrogen threshold hypothesis
3. Morphometric and electron microscopic analysis of the effects of gonadotropin-Releasing hormone agonists on uterine leiomyomas
4. Correspondence
5. Histopathologic findings in 107 uterine leiomyomas treated with leuprolide acetate compared to 126 controls
6. The relation of fibrous degeneration to menopausal status in small uterine leiomyomas, with evidence for postmenopausal origin of seedling myomas
7. Human atherosclerotic plaque cells and leiomyoma cells-Comparison of in vitro growth characteristics
8. The frequency of uterine leiomyomas
9. Growth potential of human uterine leiomyomas-Some in vitro observations and their implications
10. Human uterine leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin
11. Potential regulation of uterine leiomyomas by epidermal growth factor, platelet-derived growth factor, IGF-I, insulin, and steroids
12. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma
13. Interferon-alpha is a potent inhibitor of basic fibroblast-growth factor stimulated cell proliferation in human uterine cells
14. Pure mesenchymal neoplasms of the uterine corpus - Selected problems
15. Cellular benign mesenchymal tumors of the uterus - A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors
16. Myometrial hyperplasia - Proposed criteria for a discrete morphologic entity
17. The origin of uterine leiomyomas
18. Uterus and fallopian tubes
19. Diseases of the uterine cervix
20. The structure of the musculature of the human uterus - Muscles and connective tissue
21. Observer variability in microcompurer-assisted morphometric study of nuclear parameters
22. Interlaboratory variation in DNA flow cytometry - Results of the College of American Pathologists' Survey
23. DNA flow cytometry in solid tumors - Practical aspects and clinical applications
24. Abnormal gene expression in uterine leiomyomas
25. Uterine leiomyomas - The somatic mutation theory
26. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma - Relative expression of transforming growth factor-alpha and its receptor in different areas of the tumor